A 40-gene expression profile test can improve risk stratification for patients with CSCC, according to researchers.

Epicrispr Biotechnologies Announces FDA Clearance of IND Application for EPI-321, A First-in-Class Epigenetic Therapy for FSHD ...

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

Intermittent fasting, particularly the Ramadan Intermittent Fasting (RIF) model, has garnered significant attention in both ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

这篇发表在《自然方法》杂志上的科学文章解释了scNET如何改善医学研究并协助开发疾病治疗方法。该研究由博士生Ron Sheinin在医学院Asaf Madi教授和特拉维夫大学计算机科学与人工智能学院院长Roded Sharan教授的指导下领导。